Discover
MGRX
Mangoceuticals, Inc.
0.43
2 x 0.27
2 x 0.48
bid
ask
+
0.05
12.11%
2 @ 04:58 AM
0.42 -0.01 (1.41%)
| Ytd | -42.43% | |
| 1y | -71.79% |
0.37
day range
0.43
0.16
52 week range
2.75
| Open | 0.37 | Prev Close | 0.38 | Low | 0.37 | High | 0.43 | Mkt Cap | 7.31M |
| Vol | 509.85K | Avg Vol | 1.24M | EPS | -1.27 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.21 | Inst. Own | 4.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.39 | 200-d Avg | 0.92 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-08-25 | COHEN JACOB D. | Chief Executive Officer | 0.00 | Stock Gift |
| 2024-06-02 | D'ALESSIO LORRAINE PAMELA | Director | 175.00K | Stock Award(Grant) |
| 2024-06-25 | HAMILTON ALEX P | Director | 50.00K | Sale |
| 2024-06-02 | HAMMER AMANDA ELIZABETH | Chief Operating Officer | 175.00K | Stock Award(Grant) |
| 2023-10-02 | JOHNSTON EUGENE M | Chief Financial Officer | 200.00K | Stock Award(Grant) |
| 2024-06-02 | MYERS KENNY | Director | 175.00K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Ackerman Capital Advisors, LLC | 58.22K | 144.40K | 2.34% |
| 2024-09-29 | Captrust Financial Advisors | 17.08K | 42.35K | 0.69% |
| 2024-09-29 | Geode Capital Management, LLC | 8.76K | 21.71K | 0.35% |
| 2024-09-29 | Peak6 Investments Llc | 5.88K | 14.59K | 0.24% |
| 2024-09-29 | McCollum Christoferson Group LLC | 5.72K | 14.19K | 0.23% |
| 2024-09-29 | Two Sigma Securities, LLC | 2.52K | 6.26K | 0.10% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 6.60K | 16.38K | 0.27% |
| 2024-10-30 | Fidelity Total Market Index Fund | 3.25K | 8.05K | 0.13% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 1.58K | 3.91K | 0.06% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 452.00 | 1.12K | 0.02% |
Split
| Split | Date |
|---|---|
| 1 : 15 | 2024-10-16 |